Moderna MRNA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$1.34B-62.6% | -$826M-313% | -$200M+75.8% | -$825M+15.0% | -$971M+13.3% | ||
| $59M-11.9% | $67M+28.8% | $52M-8.8% | $57M+46.2% | $39M-35.0% | ||
| $104M-8.0% | $113M-9.6% | $125M-3.8% | $130M+13.0% | $115M+10.6% | ||
| -$114M+86.7% | -$859M-185% | $1.01B+3,477% | -$30M+89.3% | -$280M+76.8% | ||
| -$6M— | —— | $91M-20.2% | $114M+1,325% | $8M+103% | ||
| -$120M— | —— | —— | -$47M+69.9% | -$156M— | ||
| $464M— | —— | —— | -$14M+96.3% | -$381M— | ||
| -$54M+77.2% | -$237M-259% | -$66M-134% | $196M+526% | -$46M+84.2% | ||
| $26M— | —— | -$112M-93.1% | -$58M-276% | $33M-76.6% | ||
| -$6M+77.8% | -$27M-92.9% | -$14M+58.8% | -$34M-1,600% | -$2M+96.3% | ||
| $5M— | —— | $40M-58.8% | $97M+434% | -$29M+88.9% | ||
| -$7M-16.7% | -$6M-20.0% | -$5M0.0% | -$5M0.0% | -$5M— | ||
| -$2M+33.3% | -$3M— | —— | —— | -$8M+11.1% | ||
| -$630M— | —— | -$847M+7.8% | -$919M+11.4% | -$1.04B— | ||
| $62M+59.0% | $39M+18.2% | $33M+1,000% | $3M-97.4% | $117M-77.6% | ||
| $1.35B-12.9% | $1.55B+33.1% | $1.16B-10.3% | $1.3B-26.6% | $1.76B-6.6% | ||
| $602M-1.1% | $609M-11.1% | $685M+84.6% | $371M-46.1% | $688M-28.1% | ||
| $0— | —— | —— | —— | $10M— | ||
| -$76M— | $0-100% | $700M+24.1% | $564M-22.7% | $730M— | ||
| —— | $150M0.0% | $150M0.0% | $150M0.0% | $150M— | ||
| $19M+18.8% | $16M+700% | $2M-85.7% | $14M+367% | $3M-72.7% | ||
| $2M— | —— | —— | —— | $1M— | ||
| —— | $5.5M0.0% | $5.5M0.0% | $5.5M0.0% | $5.5M— | ||
| $17M-97.1% | $581M— | $0-100% | $9M+125% | $4M— | ||
| $1M— | $0-100% | $1M0.0% | $1M— | $0+100% | ||
| -$688M-147% | $1.46B+1,095% | -$147M+57.4% | -$345M-13.9% | -$303M— | ||
| —— | $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | $2.5M-58.3% | ||
| —— | $6.5M0.0% | $6.5M0.0% | $6.5M0.0% | $6.5M-86.8% | ||
| -$2M+33.3% | -$3M— | —— | —— | -$8M+11.1% | ||
| -$7M-16.7% | -$6M-20.0% | -$5M0.0% | -$5M0.0% | -$5M— | ||
| -$54M+77.2% | -$237M-259% | -$66M-134% | $196M+526% | -$46M+84.2% | ||
| -$11M-10.0% | -$10M-11.1% | -$9M+10.0% | -$10M-11.1% | -$9M— | ||
| $11M-15.4% | $13M-23.5% | $17M-5.6% | $18M-5.3% | $19M0.0% | ||
| $59M-11.9% | $67M+28.8% | $52M-8.8% | $57M+46.2% | $39M-35.0% | ||
| -$6M+77.8% | -$27M-92.9% | -$14M+58.8% | -$34M-1,600% | -$2M+96.3% | ||
| $0— | —— | —— | —— | $10M— | ||
| $732M-21.2% | $929M-23.2% | $1.21B-18.8% | $1.49B-22.9% | $1.93B+111% | ||
| $602M-1.1% | $609M-11.1% | $685M+84.6% | $371M-46.1% | $688M-28.1% | ||
| $0-100% | $12M+300% | $3M-40.0% | $5M+350% | -$2M-114% | ||
| —— | $5.5M0.0% | $5.5M0.0% | $5.5M0.0% | $5.5M— | ||
| $19M+18.8% | $16M+700% | $2M-85.7% | $14M+367% | $3M-72.7% | ||
| $35M-14.6% | $41M— | —— | —— | $50M+163% | ||
| $74M— | —— | —— | —— | $0— | ||
| —— | $6.5M0.0% | $6.5M0.0% | $6.5M0.0% | $6.5M-86.8% | ||
| -$692M— | —— | -$880M+4.6% | -$922M+20.1% | -$1.15B— | ||
| -$692M— | —— | -$880M+4.6% | -$922M+20.1% | -$1.15B— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
